# Luminous BioSolutions: Operating Model

**Version:** 1.4
**Created:** 2025-12-23
**Last Updated:** 2026-01-02
**Status:** ğŸŸ¢ Active
**Purpose:** Define how Luminous delivers Operational Intelligence for Water Release

---

## Document Index

| # | Document | Purpose | Status |
|---|----------|---------|--------|
| 01 | [[01-Service-Delivery-Process-Map]] | End-to-end workflow from sample collection to customer delivery | ğŸŸ¢ v1.1 |
| 02 | [[02-Roles-and-Responsibilities]] | Who does what (RACI matrix, role profiles) | ğŸŸ¢ v1.0 |
| 03 | [[03-Technology-Requirements]] | Systems needed, build vs. buy decisions | ğŸŸ¢ v1.0 |
| 04 | [[04-Pilot-Readiness-Scorecard]] | What exists vs. gaps, action plan | ğŸŸ¢ v1.1 |
| 05 | [[05-Pilot-Deliverables-Framework]] | Operational intelligence deliverables (5 validated scenarios + discovery) | ğŸŸ¢ v1.1 |
| 06 | [[06-Session-Summary-Operating-Model-Build]] | Session learnings and decisions | ğŸŸ¢ v1.0 |
| 07 | [[07-Strategic-Capabilities]] | Competitive advantages: Science, Technology, Commercial (investor-facing) | ğŸŸ¢ v1.0 |

---

## The Value Proposition

> **We don't just give you data. We give you decisions you couldn't make before.**

| What They Have Today | What Luminous Delivers |
|---------------------|----------------------|
| 4 data points/year (HRMS) | **100+ data points/month** |
| Feedback in 4 weeks | **Feedback in 24-72 hours** |
| Calendar-based decisions | **Evidence-based decisions** |
| "Trust us" to regulators | **"Here's the proof"** (immutable audit trail) |
| Manual regulatory reporting | **Auto-generated AER & stakeholder reports** |

---

## Proof from the Field: Kearl Wetland Pilot

The Kearl wetland study validates that high-frequency biosensor monitoring enables decisions that were previously impossible:

### Detection Reliability
- **22 of 24 OSPW samples** correctly identified as NA-positive (92% accuracy)
- Biosensor distinguished between OSPW-affected and reference waters with high confidence
- Detection range: 1.5 - 15 mg/L depending on NA type

### Correlations Discovered
| Finding | Operational Implication |
|---------|------------------------|
| **Temperature-toxicity correlation** | NA bioavailability drops below 15Â°C â†’ extend operating season by 3 weeks |
| **Spatial performance variance** | Cell 4 outperformed Cell 3 by 26% â†’ route flow to high performers |
| **Seasonal patterns** | Predictable NA dynamics across freeze/thaw cycles â†’ proactive management |

### The Key Insight
> Without high-frequency monitoring, operators make decisions based on calendar dates and gut feel. With Luminous, they make decisions based on **real-time evidence** of what's actually happening in the water.

See [[Complete Kearl Wetland Report]] for full study data.

---

## The Scientific Advantage

**Our biosensor measures what matters:**
- HRMS measures **total NAs** (poor proxy for toxicity)
- Luminous measures **bioavailable/hydrophobic fraction** (correlates with actual toxicity)
- This is validated by HRMS specialists and aligns with NA Workshop (July 2025) recommendations

---

## Validated Scenarios (Examples, Not Limits)

The following are **proven value** from Kearl, not the complete set of possibilities. A pilot with higher-frequency sampling may reveal insights we can't anticipate today.

| Scenario | Decision Enabled | Annual Value |
|----------|------------------|--------------|
| **Seasonal Strategy** | Operate 3 weeks longer (temperature-based shutdown) | $104k |
| **Spatial Optimization** | Route flow to high-performers (+26% capacity) | $78k |
| **Toxicity Validation** | Reduce expensive bio-assays by 75% | $36k |
| **Refill Management** | Resume outflow 7 days earlier per event | $14k |
| **Regulatory Reporting** | Prove data integrity with Glass Box audit trail | $24k |
| **AER Compliance** | Auto-generate regulator-ready reports | Staff time savings |
| **Indigenous Engagement** | Visual reports for community stakeholders | Relationship value |
| **TOTAL (validated)** | | **$260k/year+** |
| **+ Unknown insights** | Patterns only visible with high-frequency data | **TBD** |

> **"The pilot isn't just validation. It's exploration. We're turning on headlights in the dark."**

See [[05-Pilot-Deliverables-Framework]] for full details.

---

## Process Summary

```
CUSTOMER                    LUMINOUS
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€

 â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”    Ship      â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”    Process    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”
 â”‚ Collect â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â–¶ â”‚ Lab     â”‚â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â–¶ â”‚Platform â”‚
 â”‚ Samples â”‚              â”‚ Analysisâ”‚               â”‚ Engine  â”‚
 â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜              â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜               â””â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”˜
     â”‚                         â”‚                         â”‚
     â”‚                         â”‚ Tyson Bookout           â”‚
     â”‚                         â”‚ (Biosensor author)      â”‚
     â”‚                    â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”                    â”‚
     â”‚                    â”‚Dashboardâ”‚â—€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
     â”‚                    â”‚DECISIONSâ”‚  (not just data)
     â”‚                    â””â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”˜
     â”‚                         â”‚
     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
          Operational Intelligence
```

---

## Current Readiness: ~50% ğŸŸ¡

### âœ… Resolved
- Lab Technician: **Tyson Bookout** (biosensor paper lead author)
- Core Science: Peer-reviewed, 22/24 OSPW samples detected
- Platform Infrastructure: Squarehead Foundry base exists

### ğŸ”´ Must Resolve Before Pilot
1. **Build Customer Dashboard MVP** â†’ Owner: Greg
2. **Formalize Lab SOPs** â†’ Owner: Shawn/Tyson
3. **Sample Metadata Capture Solution** â†’ Owner: Jeff

See [[04-Pilot-Readiness-Scorecard]] for full assessment.

---

## Key Contacts

| Role             | Person            | Responsibility                                     |
| ---------------- | ----------------- | -------------------------------------------------- |
| Customer Success | Jeff Violo        | Commercial, customer relationship                  |
| Science Lead     | Shawn Lewenza     | Lab operations, biosensor science                  |
| Platform Lead    | Greg              | Data platform, dashboard, integrations             |
| Lab Technician   | **Tyson Bookout** | Day-to-day lab processing (biosensor paper author) |

---

## Related Documents

### Master Context
- [[Luminous-Master-Context]] - Company positioning and messaging
- [[Squarehead-Foundry-Master-Context]] - Commercial strategy

### Research & Validation
- [[sprint-01-upstream-optimization]] - $260k ROI analysis
- [[sprint-02-remediation-landscape]] - Complexity gap analysis
- [[sprint-04-confluent-value-map]] - Platform capabilities
- [[Complete Kearl Wetland Report]] - Field validation data

### Technical
- Biosensor publication: `04-KNOWLEDGE/1-Technical-Docs/publications/Bookout et al/`

---

## Next Steps

1. ~~Create hiring plan for lab technician~~ âœ… Tyson confirmed
2. Review these documents with Shawn and Greg
3. Make technology decisions (dashboard: Metabase vs. custom)
4. Make technology decisions (field app: Fulcrum vs. paper forms)
5. Greg to estimate platform development effort
6. Develop timeline for pilot readiness

---

## Document History

| Version | Date | Author | Changes |
|---------|------|--------|---------|
| 1.0 | 2025-12-23 | Jeff Violo / Claude | Initial creation |
| 1.1 | 2025-12-23 | Jeff Violo / Claude | Added Pilot Deliverables Framework, updated for Tyson, added Kearl insights |
| 1.2 | 2025-12-23 | Jeff Violo / Claude | Added scientific advantage (bioavailable fraction); reframed 5 scenarios as examples not limits |
| 1.3 | 2025-12-30 | Jeff Violo / Claude | Added "Proof from the Field" section with Kearl evidence; added AER/Indigenous reporting to value scenarios; enhanced value proposition table |
| 1.4 | 2026-01-02 | Jeff Violo / Claude | Added Strategic Capabilities document (07); added Session Summary (06) to index |

